You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 15, 2024

Drug Sales Trends for ATORVASTATIN CALCIUM


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for ATORVASTATIN CALCIUM (2021)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $855,948
INSIDE ANOTHER STORE $2,539,753
[disabled in preview] $8,655,734
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 68,533
INSIDE ANOTHER STORE 322,455
[disabled in preview] 505,822
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $526,809
MEDICARE $2,572,426
[disabled in preview] $8,952,199
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ATORVASTATIN CALCIUM
Drug Units Sold Trends for ATORVASTATIN CALCIUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.